Propanc Biopharma, Inc S-1, filed Oct 5, 2026

Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc. registered up to 6,500,000 shares for resale by Hexstone Capital LLC; the company receives no resale proceeds and faces substantial doubt about continuing as a going concern. AI summary